OmpK36-mediated Carbapenem resistance attenuates ST258 Klebsiella pneumoniae in vivo

Abstract Carbapenem-resistance in Klebsiella pneumoniae (KP) sequence type ST258 is mediated by carbapenemases (e.g. KPC-2) and loss or modification of the major non-selective porins OmpK35 and OmpK36. However, the mechanism underpinning OmpK36-mediated resistance and consequences of these changes o...

Full description

Bibliographic Details
Main Authors: Joshua L. C. Wong, Maria Romano, Louise E. Kerry, Hok-Sau Kwong, Wen-Wen Low, Stephen J. Brett, Abigail Clements, Konstantinos Beis, Gad Frankel
Format: Article
Language:English
Published: Nature Portfolio 2019-09-01
Series:Nature Communications
Online Access:https://doi.org/10.1038/s41467-019-11756-y
_version_ 1797840898067791872
author Joshua L. C. Wong
Maria Romano
Louise E. Kerry
Hok-Sau Kwong
Wen-Wen Low
Stephen J. Brett
Abigail Clements
Konstantinos Beis
Gad Frankel
author_facet Joshua L. C. Wong
Maria Romano
Louise E. Kerry
Hok-Sau Kwong
Wen-Wen Low
Stephen J. Brett
Abigail Clements
Konstantinos Beis
Gad Frankel
author_sort Joshua L. C. Wong
collection DOAJ
description Abstract Carbapenem-resistance in Klebsiella pneumoniae (KP) sequence type ST258 is mediated by carbapenemases (e.g. KPC-2) and loss or modification of the major non-selective porins OmpK35 and OmpK36. However, the mechanism underpinning OmpK36-mediated resistance and consequences of these changes on pathogenicity remain unknown. By solving the crystal structure of a clinical ST258 OmpK36 variant we provide direct structural evidence of pore constriction, mediated by a di-amino acid (Gly115-Asp116) insertion into loop 3, restricting diffusion of both nutrients (e.g. lactose) and Carbapenems. In the presence of KPC-2 this results in a 16-fold increase in MIC to Meropenem. Additionally, the Gly-Asp insertion impairs bacterial growth in lactose-containing medium and confers a significant in vivo fitness cost in a murine model of ventilator-associated pneumonia. Our data suggests that the continuous selective pressure imposed by widespread Carbapenem utilisation in hospital settings drives the expansion of KP expressing Gly-Asp insertion mutants, despite an associated fitness cost.
first_indexed 2024-04-09T16:22:14Z
format Article
id doaj.art-048fe9334b3d4543a8b1643b71a6d1c0
institution Directory Open Access Journal
issn 2041-1723
language English
last_indexed 2024-04-09T16:22:14Z
publishDate 2019-09-01
publisher Nature Portfolio
record_format Article
series Nature Communications
spelling doaj.art-048fe9334b3d4543a8b1643b71a6d1c02023-04-23T11:21:24ZengNature PortfolioNature Communications2041-17232019-09-0110111010.1038/s41467-019-11756-yOmpK36-mediated Carbapenem resistance attenuates ST258 Klebsiella pneumoniae in vivoJoshua L. C. Wong0Maria Romano1Louise E. Kerry2Hok-Sau Kwong3Wen-Wen Low4Stephen J. Brett5Abigail Clements6Konstantinos Beis7Gad Frankel8Centre for Molecular Bacteriology and Infection, Department of Life Sciences, Imperial College LondonDepartment of Life Sciences, Imperial College LondonCentre for Molecular Bacteriology and Infection, Department of Life Sciences, Imperial College LondonDepartment of Life Sciences, Imperial College LondonCentre for Molecular Bacteriology and Infection, Department of Life Sciences, Imperial College LondonDepartment of Surgery and Cancer, Section of Anaesthetics, Pain Medicine and Intensive Care, Imperial College LondonCentre for Molecular Bacteriology and Infection, Department of Life Sciences, Imperial College LondonDepartment of Life Sciences, Imperial College LondonCentre for Molecular Bacteriology and Infection, Department of Life Sciences, Imperial College LondonAbstract Carbapenem-resistance in Klebsiella pneumoniae (KP) sequence type ST258 is mediated by carbapenemases (e.g. KPC-2) and loss or modification of the major non-selective porins OmpK35 and OmpK36. However, the mechanism underpinning OmpK36-mediated resistance and consequences of these changes on pathogenicity remain unknown. By solving the crystal structure of a clinical ST258 OmpK36 variant we provide direct structural evidence of pore constriction, mediated by a di-amino acid (Gly115-Asp116) insertion into loop 3, restricting diffusion of both nutrients (e.g. lactose) and Carbapenems. In the presence of KPC-2 this results in a 16-fold increase in MIC to Meropenem. Additionally, the Gly-Asp insertion impairs bacterial growth in lactose-containing medium and confers a significant in vivo fitness cost in a murine model of ventilator-associated pneumonia. Our data suggests that the continuous selective pressure imposed by widespread Carbapenem utilisation in hospital settings drives the expansion of KP expressing Gly-Asp insertion mutants, despite an associated fitness cost.https://doi.org/10.1038/s41467-019-11756-y
spellingShingle Joshua L. C. Wong
Maria Romano
Louise E. Kerry
Hok-Sau Kwong
Wen-Wen Low
Stephen J. Brett
Abigail Clements
Konstantinos Beis
Gad Frankel
OmpK36-mediated Carbapenem resistance attenuates ST258 Klebsiella pneumoniae in vivo
Nature Communications
title OmpK36-mediated Carbapenem resistance attenuates ST258 Klebsiella pneumoniae in vivo
title_full OmpK36-mediated Carbapenem resistance attenuates ST258 Klebsiella pneumoniae in vivo
title_fullStr OmpK36-mediated Carbapenem resistance attenuates ST258 Klebsiella pneumoniae in vivo
title_full_unstemmed OmpK36-mediated Carbapenem resistance attenuates ST258 Klebsiella pneumoniae in vivo
title_short OmpK36-mediated Carbapenem resistance attenuates ST258 Klebsiella pneumoniae in vivo
title_sort ompk36 mediated carbapenem resistance attenuates st258 klebsiella pneumoniae in vivo
url https://doi.org/10.1038/s41467-019-11756-y
work_keys_str_mv AT joshualcwong ompk36mediatedcarbapenemresistanceattenuatesst258klebsiellapneumoniaeinvivo
AT mariaromano ompk36mediatedcarbapenemresistanceattenuatesst258klebsiellapneumoniaeinvivo
AT louiseekerry ompk36mediatedcarbapenemresistanceattenuatesst258klebsiellapneumoniaeinvivo
AT hoksaukwong ompk36mediatedcarbapenemresistanceattenuatesst258klebsiellapneumoniaeinvivo
AT wenwenlow ompk36mediatedcarbapenemresistanceattenuatesst258klebsiellapneumoniaeinvivo
AT stephenjbrett ompk36mediatedcarbapenemresistanceattenuatesst258klebsiellapneumoniaeinvivo
AT abigailclements ompk36mediatedcarbapenemresistanceattenuatesst258klebsiellapneumoniaeinvivo
AT konstantinosbeis ompk36mediatedcarbapenemresistanceattenuatesst258klebsiellapneumoniaeinvivo
AT gadfrankel ompk36mediatedcarbapenemresistanceattenuatesst258klebsiellapneumoniaeinvivo